The Blog
-
Apr 29, 2025
Inavolisib: A Breakthrough in Cancer Treatment and PI3K Inhibitio
READ MORE -
Mar 05, 2025
Resmetirom: A Breakthrough Treatment for MASH and the Future of Liver Disease Management
READ MORE -
Mar 04, 2025
Laduviglusib: A GSK3β Inhibitor with Potential Across Multiple Diseases
READ MORE -
Jul 25, 2024
Ruxolitinib: A Paradigm Shift in Myelofibrosis Treatment
READ MORE